The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus

This publication has 39 references indexed in Scilit:

• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
  BMJ, 2000
• The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.
  Diabetes Care, 1999
• Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels
  Circulation, 1998
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
  BMJ, 1998
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it?
  The Lancet, 1997
• Detection and Management of Lipid Disorders in Diabetes
  Diabetes Care, 1993
• Cause-specific mortality in a population-based study of diabetes.
  American Journal of Public Health, 1991
• A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates
  Diabetologia, 1990